✨ Health Notices
NEW ZEALAND GAZETTE, No. 110
11 OCTOBER 2007
Health
Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003
Northern region being the geographical area including Auckland and Northland:
Geoff Pratt
Revocation of Appointment as Compulsory Care Co-ordinator
The revocation of this appointment takes effect on the date this notice is published in the New Zealand Gazette.
Under section 140 of the Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003, I revoke the appointment of the following person as a compulsory care co-ordinator for the named geographical and operational area listed below.
Dated at Wellington this 10th day of September 2007.
STEPHEN McKERNAN, Director-General of Health.
go7065
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Aspen Adrenaline |
|---|---|
| Active Ingredient: | Adrenaline 1mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy |
| Product: | BLES |
|---|---|
| Active Ingredient: | Bovine lung lipids 27mg/mL |
| Dosage Form: | Intratracheal suspension |
| New Zealand Sponsor: | REX Medical Limited |
| Manufacturer: | BLES Biochemicals Inc., London, Ontario, Canada |
Dated this 4th day of October 2007.
LES STEPHENS, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6987
Renewal of Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Actigall |
|---|---|
| Active Ingredient: | Ursodeoxycholic acid 300mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Novartis New Zealand Limited Pharmaceutical Sector |
| Manufacturer: | Watson Laboratories Inc, Carmel NY, United States of America |
| Note: | This consent is valid for two years from 29 September 2007. |
| Product: | Apo-Primidone |
|---|---|
| Active Ingredient: | Primidone 250mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Apotex NZ Limited |
| Manufacturer: | Apotex Inc, Weston, Ontario, Canada |
| Note: | This consent is valid for two years from 1 November 2007. |
| Product: | Glivec |
|---|---|
| Active Ingredient: | Imatinib mesilate 119.5mg equivalent to 100mg imatinib base |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Novartis New Zealand Limited Pharmaceutical Sector |
| Manufacturer: | Novartis Pharma Stein AG, Stein, Switzerland |
| Note: | This consent is valid for two years from 18 October 2007. |
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 110
Gazette.govt.nz —
NZ Gazette 2007, No 110
✨ LLM interpretation of page content
🏥 Revocation of Compulsory Care Co-ordinator Appointment
🏥 Health & Social Welfare10 September 2007
Compulsory Care, Revocation, Appointment, Northern Region, Auckland, Northland
- Geoff Pratt, Revoked as Compulsory Care Co-ordinator
- Stephen McKernan, Director-General of Health
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare4 October 2007
Medicines, Distribution, Consent, Adrenaline, BLES
- Les Stephens, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Renewal of Provisional Consent to Distribution of New Medicines
🏥 Health & Social Welfare4 October 2007
Medicines, Provisional Consent, Renewal, Actigall, Apo-Primidone, Glivec
- Les Stephens, Acting Deputy Director-General, Sector Accountability and Funding Directorate